0491312 - ÚOCHB 2019 RIV US eng J - Journal Article
Zhang, Y. - Gao, Y. - Zhang, H. - Zhang, J. - He, F. - Hnízda, Aleš - Qian, M. - Liu, X. M. - Gocho, Y. - Pui, C. H. - Cheng, T. - Wang, Q. - Yang, J. J. - Zhu, X. - Liu, X.
PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia.
Blood. Roč. 131, č. 20 (2018), s. 2256-2261. ISSN 0006-4971. E-ISSN 1528-0020
R&D Projects: GA ČR GA15-06582S
Institutional support: RVO:61388963
Keywords : children’s oncology group * high-risk * imatinib
OECD category: Biochemistry and molecular biology
Impact factor: 16.601, year: 2018
http://www.bloodjournal.org/content/131/20/2256
Permanent Link: http://hdl.handle.net/11104/0285303
Zhang, Y. - Gao, Y. - Zhang, H. - Zhang, J. - He, F. - Hnízda, Aleš - Qian, M. - Liu, X. M. - Gocho, Y. - Pui, C. H. - Cheng, T. - Wang, Q. - Yang, J. J. - Zhu, X. - Liu, X.
PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia.
Blood. Roč. 131, č. 20 (2018), s. 2256-2261. ISSN 0006-4971. E-ISSN 1528-0020
R&D Projects: GA ČR GA15-06582S
Institutional support: RVO:61388963
Keywords : children’s oncology group * high-risk * imatinib
OECD category: Biochemistry and molecular biology
Impact factor: 16.601, year: 2018
http://www.bloodjournal.org/content/131/20/2256
Permanent Link: http://hdl.handle.net/11104/0285303